Radiofrequency ablation of hepatocellular carcinoma

Journal of Medical Ultrasound

Volumn 16, Issue 4, 2008, Pages 272-284

  Chiou, Yi You ^a   Chou, Yi Hong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Hepatocelluar carcinoma; Liver neoplasm; Radiofrequency ablation; Therapy; Thermal ablation

Indexed keywords

ASCITES; BILE DUCT OBSTRUCTION; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLON INJURY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAPHRAGM INJURY; DUODENUM INJURY; EFFUSION; GALLBLADDER DISEASE; HEMATOMA; HUMAN; HYPERKALEMIA; IMAGE ANALYSIS; INFECTION; LIVER CELL CARCINOMA; LUNG INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT SAFETY; PLEURA DISEASE; RADIOFREQUENCY ABLATION; REVIEW; STOMACH INJURY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THERMAL INJURY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT RESPONSE; TUMOR VOLUME; VEIN THROMBOSIS;

EID: 59149095872     PISSN: 09296441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6441(09)60005-9     Document Type: Review

References (69)

1. Schafer DF, Sorrel MF. Hepatocellular carcinoma. Lancet 1999;353:1253-7.
2. Fan ST, Lai EC, Lo CM, et al. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995;130: 198-203.
3. Johnson R. Hepatocellular carcinoma. Hepatogastroenterology 1997;44:307-12.
4. Dodd G, Soulen M, Kane R, et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000;20:9-27.
5. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
6. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001;6:14-23.
7. Higgins H, Berger DL. RFA for liver tumors: does it really work? Oncologist 2006;11:801-8.
8. Buscarini E, Savoia A, Brambilla G, et al. Radiofrequency thermal ablation of liver tumors. Eur Radiol 2005;15:884-94.
9. Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results and new promises. Invest Radiol 2004;39:689-97.
10. Lorentzen T. A cooled needle electrode for radiofrequency tissue ablation: thermodynamic aspects of improved performance compared with conventional needle design. Acad Radiol 1996;3:556-63.
11. Solbiati L, Goldberg SN, lerace T, et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997;205:367-73.
12. Lim HK. Radiofrequency thermal ablation of hepatocellular carcinomas. Korean Journal of Radiology 2000;1: 175-84.
13. Denys AL, De Baere T, Kuoch V, et al. Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol 2003;13:2346-52.
14. McGahan JP, Dodd GD. RF ablation of the liver current status. AJR Am J Roentgenol 2001;176:3-16.
15. De Baere T, Denys A, Wood B, et al. RF liver ablation: experimental comparative study of water-cooled versus expandable system. AJR Am J Roentgenol 2001;176: 187-92.
16. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with RF using multiprobe arrays. Acad Radiol 1995;2:670-4.
17. Miao Y, Ni Y, Yu J, Marchal G. A comparative study on validation of a novel cooled-wet electrode for RF liver ablation. Invest Radiol 2000;35:438-44.
18. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 2001;26:345-60.
19. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000;174: 323-31.
20. Lencioni R, Cioni D, Goletti O, et al. Radiofrequency thermal ablation of liver tumors: state-of-the-art. Cancer J 2000;6(Suppl 4):S304-15.
21. Chiou YY, Chou YH, Chiang JH, Wang HK, Chang CY. Percutaneous ultrasound-guided radiofrequency ablation of colorectal liver metastases. Chin J Radiol 2005; 30:153-8.
22. Livraghi T, Goldberg SN, Lazzaroni S. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761-8.
23. Giovannini M, Moutardier V, Danisi C, Bories E, Pesenti C, Delpero JR. Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermoablation: results and outcomes in 56 patients. J Gastrointest Surg 2003;7:791-6.
24. Chiou YY, Hwang JI, Chou YH, Wang HK, Chiang JH, Chang CY. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J Med Sci 2005;21:304-9.
25. Lu DS, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005;41: 1130-7.
26. Wagner AA, Solomon SB, Su LM. Treatment of renal tumors with radiofrequency ablation. J Endourol 2005; 19:643-52; discussion 652-3.
27. Gillams AR. The use of radiofrequency in cancer. Br J Cancer 2005;92:1825-9.
28. Chiou YY, Hwang JI, Chou YH, Wang JH, Chiang JH, Chang CY. Percutaneous radiofrequency ablation of renal cell carcinoma. J Chin Med Assoc 2005;68:221-5.
29. Gillams AR. Imaging guided tumor ablation. Cancer Imaging 2005;21:103-9.
30. Jindal G, Friedman M, Locklin J, Wood BJ. Palliative radiofrequency ablation for recurrent prostate cancer. Cardiovasc Intervent Radiol 2006;29:482-5.
31. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
32. Johnson EW, Holck PS, Levy AE, et al. The role of tumor ablation in bridging patients to liver transplantation. Arch Surg 2004;139:825-9; discussion 829-830.
33. Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation 2005; 80(Suppl 1):S113-9.
34. Curley SA, Izzo F. Radiofrequency ablation of primary and metastatic hepatic malignancies. Int J Clin Oncol 2002;7:72-81.
35. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-51.
36. Buscarini E, Buscarini L. Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report. Eur Radiol 2004;14:31-7.
37. Rhim H, Dodd GD 3rd, Chintapalli KN, et al. Radio-frequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 2004;24:41-52.
38. Gillams A, Lees W. Liver isolation during RF ablation. Radiology 2003;9(P) 589.
39. Limanond P, Zimmerman P, Raman SS, Kadell BM, Lu DSK. Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. AJR Am J Roentgenol 2003;181:1635-40.
40. Choi D, Lim HK, Lee WJ, et al. Evaluation of therapeutic response in hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent-preliminary results. Radiology 2000;217: 558-63.
41. Cioni D, Lencioni R, Rossi S, et al. RF ablation of HCC: using contrast enhanced harmonic power Doppler sonography to assess treatment outcome. Am J Roentgenol 2003;226:441-51.
42. Kim CK, Choi D, Lim HK, et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005; 56:66-73.
43. Lu MD, Yu XL, Li AH, et al. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Ultrasound Med Biol 2007;33:1736-49.
44. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radiofrequency ablation: CT and MR imaging follow-up. Radiology 2002;223: 255-62.
45. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radio-frequency ablation. Radiology 2005;234:961-7.
46. Raut CP, Izzo F, Marra P, et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 2005;12:616-28.
47. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005:103:1201-9.
48. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11:914-21.
49. Guglielmi A, Ruzzenente A, Battocchia A, et al. Radio-frequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 2003;50: 480-4.
50. Shibata T, Shibata T, Maetani Y, et al. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology 2006;238:346-53.
51. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321-8.
52. Sotiropoulos GC, Malago M, Molmenti EP, et al. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments. Eur J Med Res 2005;10:539-42.
53. Pompili M, Mirante VG, Rondinara G, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 2005; 11:1117-26.
54. Lu DS, Yu NC, Raman SS, et al. Percutaneous radio-frequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005;41: 1130-7.
55. Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240:900-9.
56. Hertl M, Cosimi AB. Liver transplantation for malignancy. Oncologist 2005;10:269-81.
57. Yu HC, Cheng JS, Lai KH, et al. Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 2005;11:1439-44.
58. Iannitti DA, Dupuy DE, Mayo-Smith WW, et al. Hepatic radiofrequency ablation. Arch Surg 2002;137: 422-6.
59. Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 2008;195:508-20.
60. Rhim H, Yoon K, Lee J, et al. Major complications after radiofrequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 2003;23:123-34; discussion 134-6.
61. Mulier S, Mulier P, Ni Y, et al. Complications of RF coagulation of liver tumors. Br J Surg 2002;89: 1206-22.
62. Rhim H, Dodd G, Chintapalli K, et al. RF thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 2004;24:41-52.
63. de Baere T, Risse O, Kuoch V, et al. Adverse events during RF treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003;181:695-700.
64. Rhim H, Dodd GD. RF thermal ablation of liver tumors. J Clin Ultrasound 1999;27:221-9.
65. Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004;239: 450-8.
66. Verhoeven B, Haagsma E, Appeltans B, Slooff M, De Jong K. Hyperkalemia after RF ablation of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2002; 14:1023-4.
67. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous RF ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-9.
68. Liu C, Frilling A, Dereskewitz C, Broelsch CE. Tumor seeding after fine needle aspiration biopsy and percutanous RF thermal ablation of hepatocellular carcinoma. Dig Surg 2003;20:460-3.
69. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-51.